Dello Russo, Cinzia https://orcid.org/0000-0002-2538-3832
Cappoli, Natalia
Coletta, Isabella
Mezzogori, Daniele
Paciello, Fabiola
Pozzoli, Giacomo
Navarra, Pierluigi
Battaglia, Alessandra
Funding for this research was provided by:
Angelini S.P.A
Università Cattolica del Sacro Cuore - Fondi di Ateneo
Article History
Received: 12 June 2018
Accepted: 21 August 2018
First Online: 10 September 2018
Ethics approval and consent to participate
: All the experiments were carried out on the human microglial cell line, HMC3 (ATCC®CRL-3304) cells authenticated and distributed by ATCC®. The cell line has been used under the term and conditions indicated in the approved material transfer agreement. The use of a single anonymized human genomic DNA sample was authorized by ViiV Healthcare Ldt., under the terms and conditions signed by the Italian HLA-B*57:01 Virological-Clinical Network. Ethics approval was not required since the sample derived from a previous study is approved by the local Ethical Committee which comprised future use for methodological studies [].
: We used a single anonymized human genomic DNA sample provided by ViiV Healthcare Ltd., for which consent for publication is not required [].
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.